Sobi negotiates sale of its Partner Products business area

Swedish Orphan Biovitrum is negotiating with a private equity firm regarding a possible sale of its Partner Products business area excluding Kineret and Orfadin. 

The company has confirmed negotiations in its press release issued on Friday, and noted that the discussions may or may not lead to an agreement.